We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
Resideo Technologies
REZI
$2.84B
| $3.69M | ﹤0.01% |
118,542
-4,313
| -4% | -$148K |
2019 Q1
29 quarters
|
|
2202
Patria Investments
PAX
$1.49B
| $3.67M | ﹤0.01% |
334,591
+173,616
| +108% | +$2.07M |
2024 Q4
6 quarters
|
|
2203
iShares Silver Trust
SLV
$24B
| $3.67M | ﹤0.01% |
68,626
+7,743
| +13% | +$513K |
2025 Q3
3 quarters
|
|
2204
StoneCo
STNE
$1.79B
| $3.66M | ﹤0.01% |
338,350
+152,486
| +82% | +$1.81M |
2025 Q1
5 quarters
|
|
2205
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.14B
| $3.65M | ﹤0.01% |
68,529
-2,224
| -3% | -$116K |
2025 Q1
5 quarters
|
|
2206
Power Integrations
POWI
$2.45B
| $3.65M | ﹤0.01% |
43,596
-93,779
| -68% | -$6.77M |
2019 Q3
27 quarters
|
|
2207
Accendra Health
ACH
$19.5M
| $3.65M | ﹤0.01% |
1,067,324
+335,103
| +46% | +$1.04M |
2018 Q1
33 quarters
|
|
2208
Teva Pharmaceutical Industries Limited
TEVA
$49.1B
| $3.65M | ﹤0.01% |
107,729
+32,511
| +43% | +$1.08M |
2024 Q2
8 quarters
|
|
2209
Starwood Property Trust
STWD
$4.52B
| $3.64M | ﹤0.01% |
222,282
+66,731
| +43% | +$1.16M |
2024 Q2
8 quarters
|
|
2210
Frontier Group Holdings
ULCC
$1.49B
| $3.64M | ﹤0.01% |
460,178
+265,750
| +137% | +$1.37M |
2024 Q3
7 quarters
|
|
2211
Champion Homes
SKY
$4.6B
| $3.63M | ﹤0.01% |
41,191
+10,006
| +32% | +$766K |
2025 Q3
3 quarters
|
|
2212
Amerant Bancorp
AMTB
$1.19B
| $3.63M | ﹤0.01% |
142,084
-37,823
| -21% | -$881K |
2024 Q3
7 quarters
|
|
2213
Vanguard Russell 2000 ETF
VTWO
$16.7B
| $3.62M | ﹤0.01% |
29,836
+5,249
| +21% | +$596K |
2024 Q3
7 quarters
|
|
2214
Cytek Biosciences
CTKB
$797M
| $3.61M | ﹤0.01% |
813,971
-98,371
| -11% | -$420K |
2023 Q2
12 quarters
|
|
2215
BGC Group
BGC
$5.24B
| $3.61M | ﹤0.01% |
337,233
+144,754
| +75% | +$1.62M |
2022 Q4
14 quarters
|
|
2216
On Holding
ONON
$11.3B
| $3.6M | ﹤0.01% |
101,583
-39,468
| -28% | -$1.44M |
2025 Q2
4 quarters
|
|
2217
Choice Hotels
CHH
$5B
| $3.6M | ﹤0.01% |
32,622
+3,258
| +11% | +$360K |
2016 Q2
40 quarters
|
|
2218
Tredegar Corp
TG
$261M
| $3.6M | ﹤0.01% |
451,880
+365,977
| +426% | +$3.11M |
2024 Q2
8 quarters
|
|
2219
Swan Hedged Equity US Large Cap ETF
HEGD
$733M
| $3.59M | ﹤0.01% |
+134,801
| New | +$3.54M |
2026 Q2
0 quarters
|
|
2220
Resources Connection
RGP
$92.3M
| $3.59M | ﹤0.01% |
844,437
+63,425
| +8% | +$266K |
2017 Q2
36 quarters
|
|
2221
Dimensional International High Profitability ETF
DIHP
$6.51B
| $3.58M | ﹤0.01% |
104,979
+52,988
| +102% | +$1.79M |
2024 Q4
6 quarters
|
|
2222
Verastem
VSTM
$1.18B
| $3.57M | ﹤0.01% |
934,565
+868,500
| +1,315% | +$4.2M |
2024 Q3
7 quarters
|
|
2223
Option Care Health
OPCH
$4.77B
| $3.57M | ﹤0.01% |
170,159
+104,441
| +159% | +$2.43M |
2024 Q4
6 quarters
|
|
2224
Primis Financial Corp
FRST
$365M
| $3.57M | ﹤0.01% |
217,841
+109,703
| +101% | +$1.6M |
2024 Q1
9 quarters
|
|
2225
Equity Bancshares
EQBK
$1B
| $3.56M | ﹤0.01% |
72,624
+16,493
| +29% | +$761K |
2024 Q2
8 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.